You will not be allowed to compare more than 4 products at a time
View compare
About Us
At Medolife SRL, we are redefining the future of complementary cancer care through groundbreaking venom research and its medicinal application. Our mission is to improve the quality of life of cancer patients by offering innovative, natural therapies that complement conventional treatments. With our flagship product, Escozine, we have harnessed the healing power of nature to support patients on their road to recovery, backed by advanced science and ethical practices.
A Journey of Discovery and Innovation
The origins of Medolife SRL date back to 2004, when our founder, Dr. Arthur Mikaelian, began researching the therapeutic potential of scorpion venom in collaboration with Cuban scientists. His passion for finding natural solutions to life-threatening diseases led him, in 2008, to the Dominican Republic, where he discovered the unique properties of the Rhopalurus princeps scorpion. This discovery paved the way for the creation of Escozine, a revolutionary biological therapy designed to improve the lives of cancer patients.
Escozine represents a breakthrough in complementary medicine, using a patented polarization technology to amplify the therapeutic effects of venom-derived peptides. Today, Medolife SRL is at the forefront of venom peptide-based therapies, with Escozine benefiting thousands of patients worldwide.
A Unique Alliance with Nature
What truly sets Medolife SRL apart is our deep connection to nature. We are proud to operate scorpion reserves in collaboration with the Dominican Republic’s Ministry of Environment, where we ethically source venom from the Rhopalurus princeps scorpion. These reserves are a carefully managed, sustainable environment that ensures the health and vitality of the scorpion population, while providing a constant source of venom for our research and production.
Our approach to venom extraction is based on ethical and sustainable practices. Scorpions are not harmed in the process and their natural habitats are preserved. This commitment to environmental stewardship allows us to produce Escozine responsibly, ensuring the longevity of this vital resource. For Medolife SRL, these scorpion reserves are not just a source of material, but a symbol of our dedication to both scientific innovation and environmental conservation.
Global Research Recognition
Our innovative work has allowed us to collaborate with some of the most prestigious medical institutions in the world. These collaborations have allowed us to conduct robust preclinical and clinical trials, continuously validating Escozine’s efficacy in improving patients’ quality of life and enhancing the effects of traditional cancer treatments.
More than 12 years of research and case studies demonstrate Escozine’s potential to reduce pain, increase energy and help patients recover more quickly from chemotherapy and radiation. As more research emerges, Escozine is gaining worldwide recognition as a powerful complementary therapy for cancer patients.
